Biosensors   

Is Biosensors a good buy?

if today volumn still higher than average volumn, a bull is appear to rally. waiting up to 1.45. this counter silent too long, so many investor waiting his action (news). now almost the time to enter and wait for the harvest!

believe, company will release more good news to push the share up! 

skk888      ( Date: 27-Nov-2012 13:39) Posted: already closed the position.. 1.14 is the key resistance to cross to have further upside i think.. monitoring to re-enter again..

 

haha there you are.... i sold off at 113 but re entered again at 1135... 10 lots...hold for long. may add more if drop ........ ...heehee...anyway this stock has long been in the doldrums.... time to spike ...go go go Bios!!!!!

halleluyah      ( Date: 27-Nov-2012 13:00) Posted: Bro tea  finally u bot.  The other day ask u was so much cheaper 1.08. Anyway neber too late.  I add in  some tdy also.  Gd luck. tea444u      ( Date: 27-Nov-2012 12:55) Posted: i am with you on this... ntered 1.1

 

already closed the position.. 1.14 is the key resistance to cross to have further upside i think..
monitoring to re-enter again..

 

what shall be u guys TP? oh and welcome onboard! i praying for burst like ytd

 

Bro tea  finally u bot.  The other day ask u was so much cheaper 1.08. Anyway neber too late.  I add in  some tdy also.  Gd luck.

tea444u      ( Date: 27-Nov-2012 12:55) Posted: i am with you on this... ntered 1.11 skk888      ( Date: 27-Nov-2012 10:55) Posted: opps 1.11.. Anyone has other views why it went down beside short sellers? Am new to Biosensors.. :

 

i am with you on this... ntered 1.11

skk888      ( Date: 27-Nov-2012 10:55) Posted: opps 1.11.. Anyone has other views why it went down beside short sellers? Am new to Biosensors.. :) skk888      ( Date: 27-Nov-2012 10:51) Posted: Seems like theres supprt at 1.1. Just entered long here. Company's latest quarterly result was good... Think people are concerned about the Japanese license.

 

well, like i once said, bio need good news and mayb div to gain support from investors.... daily buy back is not the way out in the long run

 

Without any new approval the results ahead doesn't look too good...falling ASP(average selling price) and  newer DES from rivals(Abbott and Boston Scientific just launched recently). Have to be patience.

Vested.

Splendid88      ( Date: 27-Nov-2012 11:22) Posted: Market sentiment was poor ahead of results. Co confident japan sales will pick up this quarter so no concern here. Trading at low pe because local market does not understand the sector. Largest shareholder weigao last purchase tranche was at 1.40.

 

thanks for the info!

Splendid88      ( Date: 27-Nov-2012 11:22) Posted: Market sentiment was poor ahead of results. Co confident japan sales will pick up this quarter so no concern here. Trading at low pe because local market does not understand the sector. Largest shareholder weigao last purchase tranche was at 1.40.

 

Market sentiment was poor ahead of results. Co confident japan sales will pick up this quarter so no concern here. Trading at low pe because local market does not understand the sector. Largest shareholder weigao last purchase tranche was at 1.40.

 

opps 1.11.. Anyone has other views why it went down beside short sellers?
Am new to Biosensors.. :)

skk888      ( Date: 27-Nov-2012 10:51) Posted: Seems like theres supprt at 1.1. Just entered long here. Company's latest quarterly result was good... Think people are concerned about the Japanese license.

 

Seems like theres supprt at 1.1. Just entered long here.
Company's latest quarterly result was good... Think people are concerned about the Japanese license.

 

looks like this fund seller is back from Holiday  this Tuesday morning. Need to exhaust his holding but heard he can borrow share from  other holders  to continue  shorting this stock.  

raykee      ( Date: 27-Nov-2012 09:17) Posted: Those ass releasing again......

 

same old story...

 

Those ass releasing again......

 

There is wide gap between current price and analysts price target as obvious stock was suppressed. Many good things for upside jump... ce mark approval of new tech stent anytime now, lots if cash to make impacful acquisition, china very strong growth & co says jpan will rebound. I will not rule out a takeover offer as topline revenue now close to 400m usd which is the level the big boys look for to identify targets.

 

Finally some action here! Looks like whichever company that was suppressing share price has run out of shares :)

 

btw, biosensors margin is 80% 

Splendid88      ( Date: 26-Nov-2012 21:27) Posted: Important to note that biosensors has solid fundamentals:   no debt , large cash balance, hi net margin of 35%, strong mkt share with continued growth in key geographies and strong cash flow. Company is at least 4 years ahead of its competitors with its offering of the ' gold standard 'drug eluting stent .  At current levels stock is very undervalued   and as a result the company launched a buyback program mandated for a maximum of172m shares . Thus far Nomura has maintained a 1.80 price target which based on numbers and prospect for the company does not look demanding.

 

As at Nov 26..cumulative Biosensor shares bought back is about 14mil...

 

Name of Announcer *	BIOSENSORS INT'L GROUP, LTD.
Company Registration No.	EC 24983
Announcement submitted on behalf of	BIOSENSORS INT'L GROUP, LTD.
Announcement is submitted with respect to *	BIOSENSORS INT'L GROUP, LTD.
Announcement is submitted by *	RONALD EDE
Designation *	CHIEF FINANCIAL OFFICER/ COMPANY SECRETARY
Date & Time of Broadcast	26-Nov-2012 17:36:44
Announcement No.	00067

> > ANNOUNCEMENT DETAILS

The details of the announcement start here ...

 

Name of Overseas Exchange where Company has Dual Listing (if applicable)

 

(A) Share Buy-Back Authority

 

I.

Maximum number of shares authorised for purchase*

172,353,935

 

(B) Details of Purchases Made

 

I.

Purchases made by way of market acquisition

Yes

 

If answer to the above question is Yes, please fill in the following :

 

		Singapore Exchange	Overseas Exchange
1	Date of Purchases	26-11-2012
2a	Total number of shares purchased	1,653,000
2b	Number of shares cancelled
2c	Number of shares held as treasury shares	1,653,000
3a	Price paid per share# or	Currency : S$   Amount : 1.1007	Currency : [Select Currency]   Amount :
3b	Highest price per share#	Currency : [Select Currency]   Amount :	Currency : [Select Currency]   Amount :
	Lowest price per share#	Currency : [Select Currency]   Amount :	Currency : [Select Currency]   Amount :
4	Total consideration (including stamp duties, clearing charges, etc) paid or payable for the shares#	Currency : S$   Amount : 1,820,912.67	Currency : [Select Currency]   Amount :

 

# Specify currency

 

II.

Purchases made by way of off-market acquisition on equal access scheme?

No

 

If answer to the above question is Yes, please fill in the following :

 

		Singapore Exchange	Overseas Exchange
1	Date of Purchases
2a	Total number of shares purchased
2b	Number of shares cancelled
2c	Number of shares held as treasury shares
3	Price paid or payable per share#	Currency : [Select Currency]   Amount :	Currency : [Select Currency]   Amount :
4	Total consideration (including stamp duties, clearing charges, etc) paid or payable for the shares#	Currency : [Select Currency]   Amount :	Currency : [Select Currency]   Amount :

 

# Specify currency

 

(C) Cumulative Purchases

 

	By way of market acquisition		By way of off-market acquisition on equal access scheme		Total
	No.	% 1	No.	%	No.	%
Cumulative no. of shares purchased to-date 2	14,592,000	0.847

 

1 Percentage of company's issued shares excluding treasury shares as at the date of the share buy-back resolution 2 From the date on which the share buy-back mandate is obtained

 

(D)	Number of issued shares excluding treasury shares after purchase *	1,725,902,086
	Number of treasury shares held after purchase*	14,592,000

 

Footnotes

At the date of the share buy-back resolution passed on 26 July 2012, the issued share capital of the Company comprised 1,723,539,357 ordinary shares. The total number of issued shares including treasury shares at the date of this notification is 1,740,494,086 ordinary shares.

 

displayAttachments_LN::

displayAttachmentsLength_LN::

Attachments

Total size = 0 (2048K size limit recommended)

Splendid88      ( Date: 26-Nov-2012 21:27) Posted: Important to note that biosensors has solid fundamentals:   no debt , large cash balance, hi net margin of 35%, strong mkt share with continued growth in key geographies and strong cash flow. Company is at least 4 years ahead of its competitors with its offering of the ' gold standard 'drug eluting stent .  At current levels stock is very undervalued   and as a result the company launched a buyback program mandated for a maximum of172m shares . Thus far Nomura has maintained a 1.80 price target which based on numbers and prospect for the company does not look demanding.